Company News

PharmaJet announces Quadrivalent Influenza Vaccine for Needle-free delivery begins shipping for 2017-18 flu season

GOLDEN, Colo. – Aug. 29, 2017 – PharmaJet® Inc., the maker of needle-free injection technology, today announced that shipping has begun for the quadrivalent influenza vaccine for needle-free delivery with the PharmaJet Stratis^® device for the 2017-18 influenza season.

Details

Needle-free Injection Linked to Increasing Workplace Flu Shot Compliance

GOLDEN, Colo. – June 13, 2017 – PharmaJet® Inc., the maker of needle-free injection technology, announced today that ONdrugDelivery published their study, entitled Needle-free Injection in Workplace Influenza Clinics, in its May issue.

Details

PharmaJet receives 2017 Innovation Award in Biosciences

GOLDEN, Colo. – May 11, 2017 – PharmaJet® Inc., the maker of needle-free injection technology, announced today that it received the 2017 Innovation Award in Biosciences.

Details

PharmaJet® partners with Serum Institute to Launch Needle-Free MMR Vaccine

GOLDEN, Colo. — Mar. 7, 2017 — PharmaJet, the maker of innovative, needle-free injection technology, announced its partnership with Serum Institute of India, the world’s largest vaccine manufacturer, is commercializing needle-free delivery of the MMR vaccine using the Stratis^® 0.5mL needle-free injection system.

Details

Expanded Vaccine offering for PharmaJet Needle-free Device

GOLDEN, Colo. – Feb. 14, 2017 – PharmaJet^® Inc., the maker of needle-free injection technology, today announced that needle-free delivery with the PharmaJet Stratis^® Injector is now available for both a trivalent and quadrivalent influenza vaccine for the 2017-18 influenza season.

Details

NIH Zika Vaccine Initial Trial Results Encouraging

Golden, Co. — Jan. 4 , 2017 — PharmaJet, the maker of innovative, needle-free injection technology, was featured on a CBS 60 Minutes segment concerning the National Institutes of Health DNA vaccine clinical trial for the Zika virus.

Details

PharmaJet® and Vaccibody collaborate on HPV vaccine development

GOLDEN, Colo. — Oct. 25, 2016 — PharmaJet today announced a collaboration with Vaccibody AS to provide needle-free injection technology for the study of a vaccine to eradicate HPV. This disease is the main cause of cervical cancer affecting 530,000 women globally annually

Details

PharmaJet® Needle-Free Flu Shots Offered in Workplace Health Clinics

Golden, Co. – Oct. 4, 2016 – Needle-free flu shots using the PharmaJet Injection System will be offered at workplace health clinics this flu season. Denver International Airport, Cargill, Ernst & Young and Morgan Stanley…

Details

PharmaJet® collaborates with World Health Organization

Golden, Co. — August 30, 2016 — PharmaJet today announced a multi-year agreement with the World Health Organization to provide PharmaJet’s Needle-free technology to be used in the global effort to eradicate polio.

The PharmaJet Tropis® Needle-free device has been proven to be safe, fast and easy-to-use with no possibility of needle re-use or needle sticks.

Details

NIH using PharmaJet® in DNA Vaccine Clinical Trial for Zika Virus

Golden, Co. — August 3, 2016 — PharmaJet, the maker of innovative, needle-free injection technology, announced that the National Institutes of Health will use the PharmaJet Stratis® needle-free device in a DNA vaccine clinical trial for the Zika virus.   DNA vaccines are the way of the future. Unlike traditional vaccines, like for flu or…

Details